Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Food Allergy Treatment Market Is Set to Triple — What it Means for Patients

Microbiome Therapies Show Potential in Food Allergy Research

Sublingual Epinephrine Advances as FDA Clarifies Requirements for Approval

Experimental KIC-IT Protocol Shows Early Success in Reversing Infant Food Allergies

Dupilumab Shows Promise for Patients Struggling With OIT Side Effects

Register for the FAF Summit: The Latest Cutting-Edge Developments in Food...

ARS Pharma Provides Additional Data Requested by FDA for Approval of...

Sublingual Epinephrine Takes Another Step Toward Approval in Clinical Study

Viaskin Milk Results Shows Potential for Treatment of Milk Allergy in...

Study Shows Nasal Powder Epinephrine Provides Superior Stability to EpiPens

ARS Completes Repeat Dosing Study of Nasal Epinephrine Required by FDA...

100% of Pediatric Patients with OFC Induced Anaphylaxis Responded to Single...

Nanoparticle Prevented Anaphylaxis Without Side Effects in Mouse Study

Promising Food Allergy Treatment from Aravax Receives $12 Million Investment

Update On Neffy, the Epinephrine Nasal Spray from ARS Pharma

Your School On Our Map

Put Your School on the Map